How well our brain functions depends heavily on the performance of our nerve cells. That is why they are regularly checked for their proper function — defective cell components are marked, disposed of and recycled. This includes the mitochondria, the powerhouses of our cells. Impaired quality…
Category: 5. Health
-
Discovery opens up for new ways to treat chlamydia
Researchers at Umeå University, Sweden, and Michigan State University, USA, have discovered a type of molecule that can kill chlamydia bacteria but spare bacteria that are important for health. The discovery opens the door for further research towards developing new antibiotics against…
Continue Reading
-
Evaluating the safety and efficacy of a smallpox vaccine for preventing mpox
The recent global monkeypox (mpox) outbreak, with a new and aggressive variant, has underscored the dire need for safe, broadly effective, and accessible vaccines. The LC16m8 vaccine, an attenuated vaccinia virus strain originally developed for smallpox, is a promising option for countering the…
Continue Reading
-
Biological age predicts cardiovascular disease morbidity and mortality
Looking at your biological age — how old your body really is — can give a clearer picture of your heart disease risk than traditional tools alone. This finding comes from a newly published multicentre study conducted in collaboration between the Universities of Jyväskylä, Tampere, and…
Continue Reading
-
HIV drugs offer ‘substantial’ Alzheimer’s protection, new research indicates
UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer’s disease after discovering that patients taking the drugs are substantially less likely to develop the memory-robbing condition.
The researchers, led by UVA’s Jayakrishna…
Continue Reading
-
Reactivity to tumor antigens is important for TIL therapy
A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings, published in Nature Cancer, may help improve future ways to deliver this cellular immunotherapy for…
Continue Reading
-
Engineering an antibody against flu with sticky staying power
Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the broad binding capacity of a more general immune system defender.
The protective effect was…
Continue Reading
-
Building vaccines for future versions of a virus
Effective vaccines dramatically changed the course of the COVID-19 pandemic, preventing illness, reducing disease severity, and saving millions of lives.
However, five years later, SARS-CoV-2 is still circulating, and in the process, evolving into new variants that require updated vaccines to…
Continue Reading
-
Incidence of several early-onset cancers increased between 2010 and 2019
In the United States, breast, colorectal, endometrial, pancreatic, and kidney cancers are becoming increasingly common among people under age 50, according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research (AACR).
The findings may have…
Continue Reading
-
AI-designed DNA controls genes in healthy mammalian cells for first time
A study published today in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that can successfully control gene expression in healthy mammalian cells. Researchers at the Centre for Genomic Regulation (CRG) created an AI tool which dreams up DNA…
Continue Reading